Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
NeuroMetrix, Inc. has begun shipping its SENSUS Pain Management System to the U.S. market, just weeks after receiving FDA clearance to do in late November.
The system sends electrical pulses through the skin to stimulate nerves and thereby relieve chronic pain associated with diabetic neuropathy. The stimulation is delivered at the press of a button from a lightweight, low-profile device worn on the upper calf.
SENSUS joins another NeuroMetrix product aimed at treating and managing diabetic neuropathy, the NC-stat? DPNCheckTM. The device is a rapid, accurate, and quantitative point-of-care test for detecting diabetic neuropathy at an early stage.
http://www.diabeteshealth.com/read/2013/01/28/7764/sensus-pain-management-system-now-shipping--/
The system sends electrical pulses through the skin to stimulate nerves and thereby relieve chronic pain associated with diabetic neuropathy. The stimulation is delivered at the press of a button from a lightweight, low-profile device worn on the upper calf.
SENSUS joins another NeuroMetrix product aimed at treating and managing diabetic neuropathy, the NC-stat? DPNCheckTM. The device is a rapid, accurate, and quantitative point-of-care test for detecting diabetic neuropathy at an early stage.
http://www.diabeteshealth.com/read/2013/01/28/7764/sensus-pain-management-system-now-shipping--/